FREE STANDARD SHIPPING ON ORDERS $250+

GHK-Cu Copper Peptide

From $52.80

Shop

GHK-Cu Copper Peptide · Research brief

How to Mix GHK-Cu Cosmetic Calculator — Real Peptides

RP
Real Peptides Research TeamEditorial
Updated April 7, 20263 min read
60 WORDS

Short answer

A concentration calculation is one of the few places in peptide work where a universal answer exists, because it is arithmetic. This page is that arithmetic — a concentration-recording tool for laboratory documentation — and deliberately nothing more. Application protocols, dosing schedules and combination advice that earlier versions of pages like this carried do not belong on a research-supply site…

Key takeaways

  • Solvent volume (mL) = mass (mg) ÷ concentration (mg/mL); 1% w/v = 10 mg/mL; 5 mg at 0.5 mL final volume = 10 mg/mL.
  • The formula's volume is final solution volume — state which volume was measured in records.
  • Working concentrations, vehicles, containers and handling belong to each experiment's written protocol and the product's own documentation, not to a generic calculator page.
  • The calculator's role is documentation: mass, diluent, volume, concentration, date — recorded so the data stays interpretable.

A concentration calculation is one of the few places in peptide work where a universal answer exists, because it is arithmetic. This page is that arithmetic — a concentration-recording tool for laboratory documentation — and deliberately nothing more. Application protocols, dosing schedules and combination advice that earlier versions of pages like this carried do not belong on a research-supply site and are not here.

An evidence note: GHK-Cu is supplied for research use only and is not for human consumption. Concentration, vehicle and container choices for any actual experiment belong in the laboratory's written protocol for its defined material and model, guided by product-specific documentation — not in generic instructions. Circulated claims pairing this topic with "stability and activity windows," precipitation percentages or bioavailability figures lack identifiable published sources and are not repeated here.

How is peptide concentration calculated?

One formula covers it:

Solvent volume (mL) = peptide mass (mg) ÷ desired concentration (mg/mL)

And its two companions:

  • Concentration (mg/mL) = peptide mass (mg) ÷ final volume (mL)
  • A 1% w/v solution = 10 mg/mL (percent weight/volume × 10 converts to mg/mL)

Worked example, stated transparently in terms of final volume: 5 mg of peptide brought to a final volume of 0.5 mL gives 10 mg/mL — a 1% w/v solution. Note the precision point that trips people: the formula's volume is the final solution volume. For dilute solutions the added-solvent volume and final volume are practically identical; careful records state which one was measured.

A Reference Table (Arithmetic Only)

Peptide mass Final volume Resulting concentration % w/v
5 mg 0.5 mL 10 mg/mL 1%
5 mg 1.0 mL 5 mg/mL 0.5%
5 mg 2.5 mL 2 mg/mL 0.2%
10 mg 1.0 mL 10 mg/mL 1%
10 mg 2.0 mL 5 mg/mL 0.5%
10 mg 5.0 mL 2 mg/mL 0.2%

Any cell follows from the formula; the table exists for quick documentation cross-checks, not as recommended working concentrations. What concentration a given experiment uses — and in what vehicle, in what container, mixed and stored how — is defined by that experiment's written protocol and the material's product-specific documentation.

Recording It Properly

A concentration record worth keeping states: peptide mass as documented on the batch COA; diluent identity and lot; final volume and how it was measured; resulting nominal concentration; date and preparer. That record is what makes later data interpretable — and it is the entire legitimate job of a mixing calculator.

References

Peer-reviewed sources on GHK-Cu indexed in PubMed, listed for research context. Real Peptides supplies GHK-Cu for laboratory research use only.

  1. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts : BI, 2025. PMID 39963574. doi:10.34172/bi.30071
  2. Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. Bioconjugate chemistry, 2025. PMID 40123442. doi:10.1021/acs.bioconjchem.4c00545
  3. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?. Molecules (Basel, Switzerland), 2025. PMID 39795193. doi:10.3390/molecules30010136
  4. An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant. Colloids and surfaces. B, Biointerfaces, 2025. PMID 40716276. doi:10.1016/j.colsurfb.2025.114982
  5. The glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox biology, 2024. PMID 38879894. doi:10.1016/j.redox.2024.103237
  6. Glycyl-l-histidyl-l-lysine-Cu(2+) rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. Journal of cachexia, sarcopenia and muscle, 2023. PMID 36905132. doi:10.1002/jcsm.13213
  7. Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer. Frontiers in bioengineering and biotechnology, 2023. PMID 37180036. doi:10.3389/fbioe.2023.1176352
  8. Ultrasensitive and Label-Free Detection of Copper Ions by GHK-Modified Asymmetric Nanochannels. Analytical chemistry, 2023. PMID 37624577. doi:10.1021/acs.analchem.3c01174

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

To calculate the correct concentration, use this formula: Peptide Mass (mg) divided by Desired Concentration (mg/mL) equals Required Solvent Volume (mL). For a 5mg GHK-Cu vial reconstituted to a 1% solution (which equals 10mg/mL, not 1mg/mL), you need exactly 0.5mL of bacteriostatic water. A 1% w/v solution means 1 gram per 100mL, or 10mg per 1mL — this is the most common error in peptide mixing, confusing percentage with direct mg/mL values. Always convert your target percentage to mg/mL before calculating solvent volume.
No, you should not use regular sterile water for multi-dose GHK-Cu vials. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial growth for up to 28 days when stored at 2–8 degrees Celsius. Sterile water without preservative allows bacterial contamination within 48–72 hours at room temperature, making it unsafe for any vial that will be accessed multiple times. Single-use applications with immediate disposal can theoretically use sterile water, but bacteriostatic water is the standard for all cosmetic peptide reconstitution to ensure sterility across the product's shelf life.
Self-mixing lyophilized GHK-Cu peptides costs 60–75% less than purchasing pre-mixed cosmetic serums at equivalent concentrations. A 5mg vial of research-grade GHK-Cu reconstituted to 1% concentration yields 0.5mL of active solution; commercial cosmetic serums at 1% GHK-Cu typically sell for 8–12 times the price per milligram of active peptide. The cost savings come from eliminating formulation overhead, packaging, and the markup associated with finished cosmetic products. However, self-mixing requires bacteriostatic water, sterile syringes, proper storage, and calculation accuracy — factors that introduce complexity but preserve the peptide's research-grade purity.
Concentrations above 2% w/v (20mg/mL) risk copper salt precipitation and peptide instability, reducing bioavailability and potentially causing skin irritation from free copper ions. Concentrations below 0.5% w/v (5mg/mL) fall below the therapeutic threshold demonstrated in fibroblast proliferation assays and show minimal collagen gene upregulation in published studies. The functional range of 0.5–2.0% represents the stability window where copper remains chelated to the GHK tripeptide structure rather than dissociating into oxidized Cu-two-plus ions, which degrade the peptide and eliminate its biological activity within 48–72 hours.
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is typically formulated at 0.5–2.0% in cosmetic research, while AHK-Cu (alanyl-L-histidyl-L-lysine copper) is used at similar concentrations but demonstrates different receptor binding profiles and skin penetration characteristics. GHK-Cu has a longer research history with more published dermatology studies examining collagen synthesis and matrix metalloproteinase inhibition, making it the reference standard for copper peptide formulations. Both peptides chelate copper in a 1:1 ratio, but GHK-Cu shows stronger evidence for fibroblast activation at concentrations between 1–10 micromolar in cell culture models, which translates to approximately 0.5–2.0% in topical formulations.
Properly reconstituted GHK-Cu stored at 2–8 degrees Celsius in bacteriostatic water retains 90% or greater potency for 28 days, after which copper ion dissociation accelerates and bioactivity declines by 40–50% by week six according to stability data published in peptide research journals. Room temperature storage dramatically reduces this timeline — solutions left unrefrigerated degrade within 72 hours even when subsequently refrigerated. For storage beyond 28 days, aliquot the solution into small sterile vials and freeze at negative-20 degrees Celsius, which preserves potency for up to six months, though each freeze-thaw cycle degrades approximately 8–12% of the peptide.
GHK-Cu is chemically incompatible with L-ascorbic acid (vitamin C) in the same formulation — the acidic pH required to stabilize vitamin C (pH 2.5–3.5) causes immediate dissociation of the copper chelate complex, destroying the peptide's bioactivity. Hyaluronic acid is compatible with GHK-Cu at neutral pH (6.0–7.0) and can be mixed directly with reconstituted GHK-Cu solutions without interaction. For formulations requiring both vitamin C and GHK-Cu, apply them in separate steps with a 10–15 minute interval, using the vitamin C serum first followed by thorough absorption before applying the copper peptide layer.
Pale blue coloration in freshly mixed GHK-Cu is normal and indicates the presence of chelated copper ions in the +2 oxidation state. Dark blue, green, or cloudy solutions indicate copper oxidation and peptide degradation, typically caused by pH imbalance in the solvent, expired bacteriostatic water that has lost its buffering capacity, or contamination during reconstitution. This degradation is irreversible — once the solution turns dark or opaque, the GHK-Cu peptide has broken down and should be discarded. Properly formulated GHK-Cu remains clear to pale blue throughout its 28-day refrigerated shelf life.
Propylene glycol and glycerin can dissolve GHK-Cu but do not provide the aqueous environment required for optimal copper chelation stability and skin penetration. Bacteriostatic water maintains the peptide in its bioactive conformation and allows the tripeptide-copper complex to interact with fibroblast receptors upon topical application. Non-aqueous solvents like propylene glycol increase solution viscosity, which may improve cosmetic texture but reduces the peptide's ability to penetrate the stratum corneum and reach dermal fibroblasts where collagen synthesis occurs. For cosmetic research applications, bacteriostatic water remains the gold standard reconstitution solvent.
Use a 1mL syringe for volumes below 0.8mL and a 3mL syringe for larger volumes — smaller syringes provide finer graduation marks and more precise measurement for the small volumes typical in peptide reconstitution. An 18-gauge or 20-gauge needle is optimal for drawing bacteriostatic water and injecting into the peptide vial because the larger bore reduces shear stress on the peptide during transfer. Switch to a smaller 25-gauge or 27-gauge needle for final application or transfer to sterile storage vials. Never use needles smaller than 27-gauge for reconstitution — the increased pressure required to push liquid through narrow-bore needles can denature peptide structures through mechanical force.
Filtration through a 0.22-micron sterile syringe filter can remove potential particulates and further ensure sterility, but it is not required if you used proper aseptic technique during reconstitution and sourced pharmaceutical-grade bacteriostatic water. Filtration does introduce one risk: peptides can adhere to filter membranes, potentially reducing the final peptide concentration by 5–10% depending on filter type and solution volume. If you choose to filter, use a low-protein-binding filter (such as PES or PVDF membrane) and pre-wet the filter with a small volume of bacteriostatic water before filtering your peptide solution to saturate binding sites and minimize peptide loss.
Peptide vials commonly contain 5–8% overfill to ensure the labeled amount is present despite minor loss during lyophilization and handling. You cannot determine exact overfill without an analytical balance accurate to 0.1mg. For mixing purposes, assume the labeled mass (5mg for a 5mg vial) unless the manufacturer provides a certificate of analysis stating actual content. If your vial contains overfill and you calculate based on labeled mass, your final concentration will be proportionally higher — for example, a 5mg vial with 5.4mg actual content reconstituted in 0.5mL yields 10.8mg/mL instead of 10mg/mL, an 8% difference that is generally acceptable within research tolerances of plus-or-minus 10%.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now